DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
10.52
-0.43 (-3.93%)
At close: Nov 14, 2025, 4:00 PM EST
10.60
+0.08 (0.76%)
After-hours: Nov 14, 2025, 7:21 PM EST
DENTSPLY SIRONA Revenue
DENTSPLY SIRONA had revenue of $904.00M in the quarter ending September 30, 2025, a decrease of -4.94%. This brings the company's revenue in the last twelve months to $3.62B, down -7.08% year-over-year. In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%.
Revenue (ttm)
$3.62B
Revenue Growth
-7.08%
P/S Ratio
0.58
Revenue / Employee
$258,857
Employees
14,000
Market Cap
2.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
| Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
| Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
| Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
| Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
XRAY News
- 1 day ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 9 days ago - Dentsply Sirona Stock Sinks On Missed Expectations, Lowered 2025 Guidance; CEO Unveils Return-To-Growth Plan - Benzinga
- 9 days ago - DENTSPLY SIRONA Inc. (XRAY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Dentsply Sirona Reports Third Quarter 2025 Results - GlobeNewsWire
- 22 days ago - Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 5 weeks ago - Dentsply Sirona to Host Third Quarter Conference Call on November 6th - GlobeNewsWire
- 6 weeks ago - Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization - GlobeNewsWire
- 6 weeks ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga